Serum vitamin D but not zinc levels are associated with different disease activity status in patients with inflammatory bowel disease.

Authors:
Eirini Mavropoulou
Eirini Mavropoulou
University Medical Center Goettingen
Göttingen | Germany
Volker Ellenrieder
Volker Ellenrieder
University Medical Center Goettingen
Germany
Golo Petzold
Golo Petzold
University Medicine Goettingen
Göttingen | Germany
Steffen Kunsch
Steffen Kunsch
University of Ulm
Germany
Albrecht Neesse
Albrecht Neesse
Philipps University Marburg
United Kingdom
Ahmad Amanzada
Ahmad Amanzada
University Medical Center
Germany

Medicine (Baltimore) 2019 Apr;98(15):e15172

University Medical Center Göttingen, Department of Gastroenterology and Gastrointestinal Oncology, Robert- Koch-Str., Göttingen, Germany.

The incidence of inflammatory bowel disease (IBD) is increasing and the pathogenesis is still not completely understood. Micronutrients like vitamin D [25 (OH)D] and zinc play an important role in enzyme activities and the immune system. As the 25 (OH)D-receptor has been shown to be downregulated in patients with IBD, 25 (OH)D may emerge as a predictive marker for disease improvement. Studies on relationship of both micronutrients in IBD patients are lacking.We retrospectively evaluated serum levels of 25(OH)D and zinc together with baseline characteristics of 232 IBD patients. Uni- and multivariate analyses were performed for association between serum levels of 25(OH)D and zinc with clinical and deep remission (CR and DR).155 Crohn's disease (CD) and 77 ulcerative colitis (UC) patients were included. 54% (n = 125) and 6% (n = 14) of IBD patients showed deficient serum 25(OH)D levels below 20 ng/mL and zinc levels below 7 μmol/L. Serum 25(OH)D levels were significantly higher in IBD patients with CR (P = .02) and DR (P < .001) but not serum zinc levels, respectively. Serum 25(OH)D levels (P = .008), anti-tumor-necrosis-factor-α-trough-concentration (anti-TNF-α-TC) (P = .02) and CRP level (P = .02) were independently associated with CR in CD patients. Serum 25(OH)D threshold of 19 ng/mL discriminated CD patients with or without CR, having an area under the receiver operating curve analysis (AUROC) of 0.77 [95%-confidence interval (CI): 0.68-0.85]. In multivariate analysis serum 25(OH)D levels (P = .04) and anti-TNF-α-TC (P = .04) were associated with DR in CD patients. Serum 25(OH)D threshold of 26 ng/mL discriminated CD patients with or without DR, having an AUROC of 0.75 (95%-CI: 0.68-0.83).Serum 25(OH)D (P = .04) and fecal calprotectin levels (P = .04) were independently correlated with CR in UC patients. Serum 25(OH)D threshold of 32 ng/mL discriminated UC patients in CR with an AUROC of 0.83 (95%-CI: 0.71-0.95). Zinc levels did not correlate with disease activity status in CD or UC patients either.In conclusion, beside CRP and fecal calprotectin, serum 25(OH)D levels, but not serum zinc levels, may be an additional useful and noninvasive marker for characterizing different disease activity status of IBD patients. Measurement of serum 25(OH)D in IBD patients may be warranted. 25(OH)D supplementation in deficient IBD patients is recommended.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000015172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485817PMC
April 2019
12 Reads

Publication Analysis

Top Keywords

ibd patients
16
bowel disease
8
inflammatory bowel
8
levels 25ohd
8
25ohd levels
8
zinc levels
8
25ohd zinc
8
serum levels
8
serum 25ohd
8
patients
7
ibd
6
levels
6
disease
5
serum
5
zinc
5
zinc baseline
4
25ohd
4
characteristics 232
4
multivariate analyses
4
analyses performed
4

Similar Publications